Insider Transactions in Q2 2025 at Longeveron Inc. (LGVN)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2025
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
64,158
-20.06%
|
$64,158
$1.15 P/Share
|
|
Jun 23
2025
|
Paul T Lehr General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
163,043
+33.77%
|
-
|
|
May 30
2025
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
11,000
-5.0%
|
$11,000
$1.25 P/Share
|
|
May 29
2025
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
10,000
-4.35%
|
$10,000
$1.3 P/Share
|
|
May 22
2025
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
2,000
-0.86%
|
$2,000
$1.32 P/Share
|
|
May 16
2025
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,250
-0.72%
|
$5,250
$1.4 P/Share
|
|
Apr 01
2025
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,599
-1.01%
|
$1,599
$1.5 P/Share
|
|
Apr 01
2025
|
Mohamed Wa'El Ahmed Hashad Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,384
-5.0%
|
$13,384
$1.5 P/Share
|
|
Apr 01
2025
|
Lisa Locklear Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,566
-4.97%
|
$7,566
$1.5 P/Share
|
|
Apr 01
2025
|
Nataliya Agafonova Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,566
-4.99%
|
$7,566
$1.5 P/Share
|